Bliss GVS Pharma Appoints Two Independent Directors

Bliss GVS Pharma Appoints Two Independent Directors​

Bliss GVS Pharma Limited announced the appointment of two Additional Directors, Mr. Vijayanarayanan Mahadevan and Mr. Deepak Rameshchandra Shah, on April 3, 2026. The appointments were approved by the company's Board of Directors via a circular resolution.

Mr. Mahadevan and Mr. Shah will serve as Non-Executive and Independent Directors for a term of 5 years, effective from April 3, 2026, to April 2, 2031. A Postal Ballot will be conducted to seek member approval for their appointments.

Director Profiles:

Mr. Vijayanarayanan Mahadevan is a Chartered Accountant with over 35 years of experience in finance leadership roles at companies including Alcon, Sandoz, Novartis, and SHV Energy. Mr. Deepak Rameshchandra Shah is a Fellow Member of the Institute of Chartered Accountants of India with over 36 years of experience in taxation and audit. He is currently Chairman of the Direct Taxation Committee of BCAS and serves as an Independent Director on the Boards of The Ruby Mills Limited, Marathon Nextgen Realty Limited, and Siyaram Silk Mills Limited.

Neither director is related to any other director of the company. Both directors are not debarred from holding the office of director by any regulatory authority.

Source:​